Provention Bio to Present at the Jefferies Global Healthcare Conference

Rhea-AI Summary

Provention Bio, Inc. (Nasdaq: PRVB) announced its participation in the Jefferies Global Healthcare Conference on June 8, 2022, at 9:00 am EST in New York City. The corporate presentation will be available via live webcast through the company's website, where it will be archived for 30 days post-event. Provention Bio focuses on developing therapies for immune-mediated diseases, with ongoing research in conditions like type 1 diabetes and lupus.

RED BANK, N.J., June 3, 2022 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that management will participate in a corporate presentation at the Jefferies Global Healthcare Conference on Wednesday, June 8^th 2022 at 9:00 am EST in New York City.

The presentation will be webcast live and can be accessed by visiting the Events and Webcasts section of the Company's website: http://investors.proventionbio.com/events. The webcast will be archived on the Company's website for 30 days following the presentation. 

About Provention Bio, Inc.:

Provention Bio, Inc. (Nasdaq: PRVB) is a biopharmaceutical company focused on advancing the development of investigational therapies that may intercept and prevent debilitating and life-threatening immune-mediated disease. The Company's pipeline includes clinical-stage product candidates that have demonstrated in pre-clinical or clinical studies proof-of-mechanism and/or proof-of-concept in autoimmune diseases, including type 1 diabetes, celiac disease and lupus. Visit www.ProventionBio.com for more information and follow us on Twitter: @ProventionBio.

Internet Posting of Information:

Provention Bio, Inc. uses its website, www.proventionbio.com, as a means of disclosing material nonpublic information and for complying with its disclosure obligations under Regulation F.D. Such disclosures will be included on the Company's website in the "News" section. Accordingly, investors should monitor this portion of the Company's website, in addition to following its press releases, SEC filings and public conference calls and webcasts.

Investor Contact:
Robert Doody, VP of Investor Relations
rdoody@proventionbio.com
484-639-7235

Media Contact:
Kaelan Hollon, VP, Corporate Communications
khollon@proventionbio.com
202-421-4921

View original content to download multimedia:https://www.prnewswire.com/news-releases/provention-bio-to-present-at-the-jefferies-global-healthcare-conference-301560699.html

SOURCE Provention Bio, Inc.

FAQ

When will Provention Bio present at the Jefferies Global Healthcare Conference?

Provention Bio will present on June 8, 2022, at 9:00 am EST.

How can I access the webcast of Provention Bio's presentation?

The webcast can be accessed through the Events and Webcasts section of Provention Bio's website.

What is the focus of Provention Bio's research?

Provention Bio focuses on developing therapies for immune-mediated diseases such as type 1 diabetes, celiac disease, and lupus.

Where is the Jefferies Global Healthcare Conference taking place?

The Jefferies Global Healthcare Conference is taking place in New York City.

What is the stock symbol for Provention Bio?

The stock symbol for Provention Bio is PRVB.